We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Adjuvant Zoledronic Acid in High Risk Giant Cell Tumour of Bone (GCT) (HR-GCT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00889590
Recruitment Status : Terminated (low recruitment with registration denosumab)
First Posted : April 29, 2009
Last Update Posted : January 26, 2016
Information provided by (Responsible Party):
J.R. Kroep, Leiden University Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : May 2015
  Study Completion Date : July 2015